Kin Yip Tam

Kin Yip Tam

Auto-generated profile, based on publicly available information

Kin Yip Tam

Faculty of Medicine, University of Macau, Avenida da Universidade, Taipa, 999078 Macau SAR, China

Research Focus & Metrics

Academic Career Length

35Years (1992-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 1998 in Pharmaceutical Research
Verified
Journal Article
Closed access
PDF file
AAA. Avdeef
A. Avdeef
KBK. J. Box
K. J. Box
JCJ. E. A. Comer
J. E. A. Comer
CHC. Hibbert
C. Hibbert
KTK. Y. Tam
K. Y. Tam

1 March 2013 in Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
KFKevin M. Foote
Kevin M. Foote
KBKevin Blades
Kevin Blades
ACAnna Cronin
Anna Cronin
SFShaun Fillery
Shaun Fillery
SGSylvie S. Guichard
Sylvie S. Guichard
CWChristine Wood
Christine Wood

1 August 1999 in Journal of Pharmaceutical and Biomedical Analysis
Verified
Journal Article
Closed access
AAA Avdeef
A Avdeef
KBK.J Box
K.J Box
JCJ.E.A Comer
J.E.A Comer
MGM Gilges
M Gilges
MHM Hadley
M Hadley
KTK.Y Tam
K.Y Tam

1 August 1998 in Journal of Pharmaceutical and Biomedical Analysis
Verified
Journal Article
Closed access
RAR.I. Allen
R.I. Allen
KBK.J. Box
K.J. Box
JCJ.E.A. Comer
J.E.A. Comer
CPC. Peake
C. Peake
KTK.Y. Tam
K.Y. Tam

1 January 2015 in International Journal of Biological Sciences
Verified
Journal Article
Open access
WZWen Zhang
Wen Zhang
ZZZhonglin Zang
Zhonglin Zang
XHXiaohui Hu
Xiaohui Hu
KTKin Yip Tam
Kin Yip Tam
Cancer remains a lethal threat to global lives. Development of novel anticancer therapeutics is still a challenge to scientists in the field of biomedicine. In cancer cells, the metabolic features are significantly different from those of normal ones, which are hallmarks of several malignancies. Recent studies brought atypical cellular metabolism, such as aerobic glycolysis or the Warburg effect, into the scientific limelight. Targeting these altered metabolic pathways in cancer cells presents a promising therapeutic strategy. Pyruvate dehydrogenase kinases (PDKs), key enzymes in the pathway of glucose metabolism, could inactivate the pyruvate dehydrogenase complex (PDC) by phosphorylating it and preserving the substrates pyruvate, lactate and alanine for gluconeogenesis. Overexpression of PDKs could block the oxidative decarboxylation of pyruvate to satisfy high oxygen demand in cancer cells, while inhibition of PDKs could upregulate the activity of PDC and rectify the balance between the demand and supply of oxygen, which could lead to cancer cell death. Thus, inhibitors targeting PDKs represent a promising strategy for cancer treatment by acting on glycolytic tumors while showing minimal side effects on the oxidative healthy organs. This review considers the role of PDKs as regulator of PDC that catalyzes the oxidative decarboxylation of pyruvate in mitochondrion. It is concluded that PDKs are solid therapeutic targets. Inhibition of PDKs could be an attractive therapeutic approach for the development of anti-cancer drugs.

1 April 2001 in Analytica Chimica Acta
Verified
Journal Article
Closed access
KTKin Y Tam
Kin Y Tam
KTKrisztina Takács-Novák
Krisztina Takács-Novák